KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Finished Goods (2023 - 2025)

Thermo Fisher Scientific's Finished Goods history spans 10 years, with the latest figure at $2.7 billion for Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods rose 9.88% year-over-year to $2.7 billion, compared with a TTM value of $2.7 billion through Dec 2025, up 9.88%, and an annual FY2025 reading of $2.7 billion, up 9.88% over the prior year.
  • Finished Goods for Q4 2025 was $2.7 billion at Thermo Fisher Scientific, down from $2.8 billion in the prior quarter.
  • The five-year high for Finished Goods was $2.8 billion in Q3 2025, with the low at $2.3 billion in Q4 2023.
  • Average Finished Goods over 3 years is $2.6 billion, with a median of $2.6 billion recorded in 2025.
  • Year-over-year, Finished Goods rose 4.04% in 2024 and then rose 9.88% in 2025.
  • Tracing TMO's Finished Goods over 3 years: stood at $2.3 billion in 2023, then grew by 4.04% to $2.4 billion in 2024, then rose by 9.88% to $2.7 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Finished Goods are $2.7 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.7 billion (Q2 2025).